Moderna

mRNA Vaccines Tied to Much Longer Survival in Some Patients

COVID Shot Supercharges Cancer Care? mRNA Vaccines Tied to Much Longer Survival in Some Patients, Landmark Nature Study Finds

In depth: What the new data show A team from MD Anderson and the University of Florida examined outcomes for more than a thousand patients who received immune‑checkpoint inhibitors for advanced non‑small‑cell lung cancer (NSCLC) or metastatic melanoma. Those who received a
November 1, 2025
Cancer Vaccines

The Race for Personalized mRNA Cancer Vaccines: Phase 3 Trials Aim to Transform Melanoma and Lung Cancer Treatment

Key Facts Global Phase 3 Trials: Melanoma Leads the Way The first personalized mRNA cancer vaccine to reach Phase 3 is Moderna’s mRNA-4157 (V940) in melanoma – a groundbreaking collaboration with Merck that has quickly become a bellwether for the field. Melanoma
September 13, 2025